Treatments

Inside the First FDA-Approved CAR-T Cell Therapy

ALL patients who haven’t responded to standard care have new options on the horizon, including a type of immunotherapy called CAR T-cell therapy. Learn more from Dr. Michael Deininger.

Andrew Schorr, Michael Deininger, MD, PhD

Treatments

How Can ALL Treatment Be Tailored for Me?

Dr. Elias Jabbour from The University of Texas MD Anderson Cancer Center explains how patient's individual circumstances affect treatment decisions. Watch to learn from an ALL expert.

Upcoming Events

See all events

Dec 7 2019

Saturday, December 7, 2019

Join us for the first daily wrap to hear updates about the day's events from leading hematology experts. The first 45-minute live webinar will start at 6 PM Eastern (3 PM Pacific) on Saturday, December 7, with the other daily wraps on Sunday, December 8 and Monday, December 9.

Topic Area: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia , Chronic Lymphocytic Leukemia , Chronic Myelogenous Leukemia , Hodgkin Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Myeloproliferative Neoplasms, Non-Hodgkin Lymphoma

Time: 6:00 PM – 7:00 PM Eastern Time (US and Canada)

Learn More